Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars
Crossref DOI link: https://doi.org/10.1007/s11523-017-0518-1
Published Online: 2017-08-11
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosen, Lee S.
Jacobs, Ira A.
Burkes, Ronald L.
Funding for this research was provided by:
Pfizer (Not applicable)
License valid from 2017-08-11